NGNE
#2794
Neurogene Inc. - Common Stock
38.3 2 USD
-0.03%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.31%
Monthly Change
+30.61%
6 month change
+103.29%
Year Change
+30.25%
Previous Close
39.6 3
Open
38.3 2
Low
38.3 2
High
38.3 2
Volume
33
Financials
- Market Capitalization 605.53 M
- Employee 131
- Founded 2018
- CEO Jonathan Drachman M.D.
- Website www.neurogene.com
- Headquarter New York, United States
- FIGI BBG005Y0QDK1
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.86
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2784 |  FBRX Forte Biosciences, Inc. - Common Stock | 44.12 USD | +0.46% | +113.76% | +148.70% | +50.32% | 612.64 M USD | ||
| 2789 |  MDXG MiMedx Group, Inc - Common Stock | 4.08 USD | -0.73% | -0.24% | +11.78% | -34.82% | 607.70 M USD | ||
| 2807 |  FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 11.30 USD | -8.20% | -11.72% | +25.00% | 0.00% | 590.72 M USD | ||
| 2820 |  ALT Altimmune, Inc. - Common Stock | 2.99 USD | -1.97% | -2.92% | +14.12% | -30.30% | 581.48 M USD |
Frequently asked questions about Neurogene Inc. - Common Stock
What is the Neurogene Inc. - Common Stock stock price today?
The current price of Neurogene Inc. - Common Stock (NGNE) is 38.32. Over the past 24 hours, the stock has changed by -3.31%. Follow the NGNE chart for real-time price dynamics.
What is the stock ticker of Neurogene Inc. - Common Stock?
Neurogene Inc. - Common Stock trades under the ticker NGNE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Neurogene Inc. - Common Stock stock going up?
NGNE has changed by +16.16% over the last week, +30.61% over the last month, and +30.25% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Neurogene Inc. - Common Stock net income for the last quarter?
Neurogene Inc. - Common Stock reported net income of -30.93 M for the last quarter. The previous quarter showed -24.73 M, which means net income changed by -25.06%.
How many employees does Neurogene Inc. - Common Stock have?
As of the latest available data, Neurogene Inc. - Common Stock has 131 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Neurogene Inc. - Common Stock stock?
You can buy Neurogene Inc. - Common Stock (NGNE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Neurogene Inc. - Common Stock stock?
Investing in Neurogene Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NGNE chart and related analysis on metatrader.com as part of your research.